Nuwellis (NUWE) Common Equity (2011 - 2026)
Nuwellis' (NUWE) quarterly Common Equity came in at -$2.1 million in Q2 2026, up 77.06% on a YoY basis from -$1.2 million in Q2 2025, and down 177.23% quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
Nuwellis (NUWE) Common Equity (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Common Equity for 16 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 77.06% year-over-year to -$2.1 million; the trailing twelve-month figure through Jun 2026 stood at -$2.1 million (up 77.06% YoY), and the FY2025 full-year result was $2.6 million, down 59.8% from the prior year.
- Common Equity declined to -$2.1 million in Q2 2026 per NUWE's latest filing, from $2.7 million in the prior quarter.
- Across five years, Common Equity topped out at $21.7 million in Q1 2022 and bottomed at -$9.0 million in Q2 2025.
- Historically, Common Equity has averaged $5.9 million across 5 years, with a median of $3.7 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Common Equity tumbled 161.73% in 2024, then soared 304.29% in 2025.
- Over 5 years, Common Equity stood at $12.4 million in 2022, then tumbled by 75.8% to $3.0 million in 2023, then jumped by 118.33% to $6.5 million in 2024, then slumped by 59.8% to $2.6 million in 2025, then slumped by 178.32% to -$2.1 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$2.1 million, $2.7 million, and $2.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -2.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.06 Mn |
| Mar 31, 2026 | 2.66 Mn |
| Dec 31, 2025 | 2.62 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | -8.96 Mn |
| Mar 31, 2025 | 3.58 Mn |
| Dec 31, 2024 | 6.53 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | -6.84 Mn |
| Mar 31, 2024 | 885,000.00 |
| Dec 31, 2023 | 2.99 Mn |
| Sep 30, 2023 | 7.84 Mn |
| Jun 30, 2023 | 11.07 Mn |
| Mar 31, 2023 | 13.66 Mn |
| Dec 31, 2022 | 12.36 Mn |
| Sep 30, 2022 | 14.02 Mn |
| Jun 30, 2022 | 17.66 Mn |
| Mar 31, 2022 | 21.71 Mn |
| Dec 31, 2021 | 25.95 Mn |
| Sep 30, 2021 | 29.98 Mn |